MEGAN KNOERNSCHILD: Open Payments
NPI 1255908018 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 62 payments from 19 companies in 2025. Trend: 2023 $968 · 2024 $1,425 · 2025 $1,168
Food & beverage: $1,168
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $221 |
| ABBVIE INC. | 10 | $204 |
| Lilly USA, LLC | 10 | $203 |
| Novo Nordisk Inc | 5 | $86 |
| PFIZER INC. | 4 | $64 |
| Abbott Laboratories | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
Products named: OTEZLA, MOUNJARO, VRAYLAR, ELIQUIS, FREESTYLE LIBRE 3, SHINGRIX, UBRELVY, NURTEC ODT.
Industry payments across MO — which companies pay providers there.
